Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (16)
  • Antithrombotics (214)
    • Drug-Induced Thrombosis (21)
    • Prevention (31)
    • Reversal (14)
    • Treatment (180)
      • Apixaban (Eliquis) (31)
      • Aspirin (75)
      • Clopidogrel (Plavix) (51)
      • Dabigatran (Pradaxa) (49)
      • Edoxaban (Savaysa) (12)
      • Low Molecular Weight Heparins (39)
      • Other (27)
      • Prasugrel (Effient) (22)
      • Rivaroxaban (Xarelto) (36)
      • Ticagrelor (Brilinta) (19)
      • Vorapaxar (Zontivity) (2)
      • Warfarin - Drug Interactions (30)
      • Warfarin - Treatment (65)
  • Arrhythmias (108)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (84)
  • Dyslipidemia (216)
  • Endocarditis (15)
  • Heart Disease (65)
  • Heart Failure (146)
  • Hypertension (221)
  • Hypotension (13)
  • Ischemic Heart Disease/Acute Coronary Syndromes (268)
  • Myocardial Infarction (39)
  • Peripheral Vascular Disease (5)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (648)
  • Stroke (111)
1 - 15 of 180 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Comparison of Proton Pump Inhibitors March 2022
FAQ: COVID-19 and Thromboembolism: FAQs February 2022
Chart: Anticipated Availability of First-Time Generics February 2022
FAQ: The Truth About Aspirin November 2021
Chart: Alcohol and Drug Interactions October 2021
Chart: OTC Brand-Name Extensions July 2021
FAQ: Omega-3s: Fish Oil and More January 2021
Article: Stay Alert for Patients Who May Need a Tetanus Vaccine After an Injury September 2020
Chart: Managing Bleeding With Anticoagulants September 2020
Algorithm: How to Manage High INRs in Warfarin Patients September 2020
Chart: P-glycoprotein Drug Interactions June 2020
Chart: Cytochrome P450 (CYP) Drug Interactions June 2020
Chart: Oral Meds to Keep in Original Containers April 2020
Technician Tutorial: Dispensing Meds in Original Containers April 2020
Technician Tutorial: Preventing Med Errors February 2020
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved